Marko Pesola
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Marko Pesola has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
- Harri Merisaari
FinnBrain Birth Cohort Study, Turku Brain and Mind Centre, Department of Clinical Medicine University of Turku and Turku University Hospital Turku Finland
11 shared publications Hannu J. Aronen
Department of Diagnostic Radiology, University of Turku, Turku, Finland
10 shared publications- Ivan Jambor
University of Turku
10 shared publications R. M. Nieminen
COMP/Laboratory of Physics, Helsinki University of Technology, P.O. Box 1100, FIN-02015 HUT, Finland
10 shared publicationsPekka Taimen
Institute of Biomedicine, University of Turku, Turku, Finland
9 shared publicationsPeter J. Boström
Department of Urology, University of Turku and Turku University Hospital, Turku, Finland
8 shared publications
Latest Publications
- 6 March 2021
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 54 (3) , 866-879
Whole Brain Adiabatic T1rho and Relaxation Along a Fictitious Field Imaging in Healthy Volunteers and Patients With Multiple Sclerosis: Initial Findings
Background: In preclinical models of multiple sclerosis (MS), both adiabatic T1rho (T1ρadiab) and relaxation along a fictitious field (RAFF) imaging have demonstrated potential to noninvasively characterize MS.Purpose: To evaluate the feasibility of whole brain T1ρadiab and RAFF imaging in healthy volunteers and patients with MS.Study Type: Single institutional clinical trial.Subjects: 38 healthy volunteers (24–69 years) and 21 patients (26–59 years) with MS. Five healthy volunteers underwent a second MR examination performed within 8 days. Clinical disease severity (The Expanded Disability Status Scale [EDSS] and The Multiple Sclerosis Severity Score [MSSS]) was evaluated at baseline and 1‐year follow‐up (FU).Field Strength/Sequence: RAFF in second rotating frame of reference (RAFF2) was performed at 3 T using 3D‐fast‐field echo with magnetization preparation, RF amplitude of 11.74 μT while the corresponding value for T1ρadiab was 13.50 μT. T1‐, T2‐, and FLAIR‐weighted images were acquired with reconstruction voxel size 1.0 × 1.0 × 1.0 mm3.Assessment: The parametric maps of T1ρadiab and RAFF2 (TRAFF2) were calculated using a monoexponential model. Semi‐automatic segmentation of MS lesions, white matter (WM), and gray matter (GM), and WM tracks was performed using T1‐, T2‐, and FLAIR‐weighted images.Statistical Tests: Regression analysis was used to evaluate correlation of T1ρadiab and TRAFF2 with age and disease severity while a Friedman test followed by Wilcoxon Signed Rank test for differences between tissue types. Short‐term repeatability was evaluated on voxel level.Results: Both T1ρadiab and TRAFF2 demonstrated good short‐term repeatability with relative differences on voxel level in the range of 6.1%–11.9%. Differences in T1ρadiab and TRAFF2 between the tissue types in MS patients were significant (P < 0.05). T1ρadiab and TRAFF2 correlated (P < 0.001) with baseline EDSS/MSSM and disease progression at FU (P < 0.001).Data Conclusion: Whole brain T1ρadiab and TRAFF2 at 3 T was feasible with significant differences in T1ρadiab and TRAFF2 values between tissues types and correlation with disease severity.Evidence Level: 1Technical Efficacy: Stage 1
- 6 March 2021
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 54 (3) , 866-879
Whole Brain Adiabatic T1rho and Relaxation Along a Fictitious Field Imaging in Healthy Volunteers and Patients With Multiple Sclerosis: Initial Findings
Background: In preclinical models of multiple sclerosis (MS), both adiabatic T1rho (T1ρadiab) and relaxation along a fictitious field (RAFF) imaging have demonstrated potential to noninvasively characterize MS.Purpose: To evaluate the feasibility of whole brain T1ρadiab and RAFF imaging in healthy volunteers and patients with MS.Study Type: Single institutional clinical trial.Subjects: 38 healthy volunteers (24–69 years) and 21 patients (26–59 years) with MS. Five healthy volunteers underwent a second MR examination performed within 8 days. Clinical disease severity (The Expanded Disability Status Scale [EDSS] and The Multiple Sclerosis Severity Score [MSSS]) was evaluated at baseline and 1‐year follow‐up (FU).Field Strength/Sequence: RAFF in second rotating frame of reference (RAFF2) was performed at 3 T using 3D‐fast‐field echo with magnetization preparation, RF amplitude of 11.74 μT while the corresponding value for T1ρadiab was 13.50 μT. T1‐, T2‐, and FLAIR‐weighted images were acquired with reconstruction voxel size 1.0 × 1.0 × 1.0 mm3.Assessment: The parametric maps of T1ρadiab and RAFF2 (TRAFF2) were calculated using a monoexponential model. Semi‐automatic segmentation of MS lesions, white matter (WM), and gray matter (GM), and WM tracks was performed using T1‐, T2‐, and FLAIR‐weighted images.Statistical Tests: Regression analysis was used to evaluate correlation of T1ρadiab and TRAFF2 with age and disease severity while a Friedman test followed by Wilcoxon Signed Rank test for differences between tissue types. Short‐term repeatability was evaluated on voxel level.Results: Both T1ρadiab and TRAFF2 demonstrated good short‐term repeatability with relative differences on voxel level in the range of 6.1%–11.9%. Differences in T1ρadiab and TRAFF2 between the tissue types in MS patients were significant (P < 0.05). T1ρadiab and TRAFF2 correlated (P < 0.001) with baseline EDSS/MSSM and disease progression at FU (P < 0.001).Data Conclusion: Whole brain T1ρadiab and TRAFF2 at 3 T was feasible with significant differences in T1ρadiab and TRAFF2 values between tissues types and correlation with disease severity.Evidence Level: 1Technical Efficacy: Stage 1
- 8 November 2019
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 83 (6) , 2293-2309
Repeatability of radiomics and machine learning for DWI: Short‐term repeatability study of 112 patients with prostate cancer
Purpose: To evaluate repeatability of prostate DWI‐derived radiomics and machine learning methods for prostate cancer (PCa) characterization.Methods: A total of 112 patients with diagnosed PCa underwent 2 prostate MRI examinations (Scan1 and Scan2) performed on the same day. DWI was performed using 12 b‐values (0–2000 s/mm2), post‐processed using kurtosis function, and PCa areas were annotated using whole mount prostatectomy sections. A total of 1694 radiomic features including Sobel, Kirch, Gradient, Zernike Moments, Gabor, Haralick, CoLIAGe, Haar wavelet coefficients, 3D analogue to Laws features, 2D contours, and corner detectors were calculated. Radiomics and 4 feature pruning methods (area under the receiver operator characteristic curve, maximum relevance minimum redundancy, Spearman’s ρ, Wilcoxon rank‐sum) were evaluated in terms of Scan1‐Scan2 repeatability using intraclass correlation coefficient (ICC)(3,1). Classification performance for clinically significant and insignificant PCa with Gleason grade groups 1 versus >1 was evaluated by area under the receiver operator characteristic curve in unseen random 30% data split.Results: The ICC(3,1) values for conventional radiomics and feature pruning methods were in the range of 0.28–0.90. The machine learning classifications varied between Scan1 and Scan2 with % of same class labels between Scan1 and Scan2 in the range of 61–81%. Surface‐to‐volume ratio and corner detector‐based features were among the most represented features with high repeatability, ICC(3,1) >0.75, consistently high ranking using all 4 feature pruning methods, and classification performance with area under the receiver operator characteristic curve >0.70.Conclusion: Surface‐to‐volume ratio and corner detectors for prostate DWI led to good classification of unseen data and performed similarly in Scan1 and Scan2 in contrast to multiple conventional radiomic features.
- 8 November 2019
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 83 (6) , 2293-2309
Repeatability of radiomics and machine learning for DWI: Short‐term repeatability study of 112 patients with prostate cancer
Purpose: To evaluate repeatability of prostate DWI‐derived radiomics and machine learning methods for prostate cancer (PCa) characterization.Methods: A total of 112 patients with diagnosed PCa underwent 2 prostate MRI examinations (Scan1 and Scan2) performed on the same day. DWI was performed using 12 b‐values (0–2000 s/mm2), post‐processed using kurtosis function, and PCa areas were annotated using whole mount prostatectomy sections. A total of 1694 radiomic features including Sobel, Kirch, Gradient, Zernike Moments, Gabor, Haralick, CoLIAGe, Haar wavelet coefficients, 3D analogue to Laws features, 2D contours, and corner detectors were calculated. Radiomics and 4 feature pruning methods (area under the receiver operator characteristic curve, maximum relevance minimum redundancy, Spearman’s ρ, Wilcoxon rank‐sum) were evaluated in terms of Scan1‐Scan2 repeatability using intraclass correlation coefficient (ICC)(3,1). Classification performance for clinically significant and insignificant PCa with Gleason grade groups 1 versus >1 was evaluated by area under the receiver operator characteristic curve in unseen random 30% data split.Results: The ICC(3,1) values for conventional radiomics and feature pruning methods were in the range of 0.28–0.90. The machine learning classifications varied between Scan1 and Scan2 with % of same class labels between Scan1 and Scan2 in the range of 61–81%. Surface‐to‐volume ratio and corner detector‐based features were among the most represented features with high repeatability, ICC(3,1) >0.75, consistently high ranking using all 4 feature pruning methods, and classification performance with area under the receiver operator characteristic curve >0.70.Conclusion: Surface‐to‐volume ratio and corner detectors for prostate DWI led to good classification of unseen data and performed similarly in Scan1 and Scan2 in contrast to multiple conventional radiomic features.
- Open Access
- 8 July 2019
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (7) , e0217702
Radiomics and machine learning of multisequence multiparametric prostate MRI: Towards improved non-invasive prostate cancer characterization
To develop and validate a classifier system for prediction of prostate cancer (PCa) Gleason score (GS) using radiomics and texture features of T2-weighted imaging (T2w), diffusion weighted imaging (DWI) acquired using high b values, and T2-mapping (T2). T2w, DWI (12 b values, 0–2000 s/mm2), and T2 data sets of 62 patients with histologically confirmed PCa were acquired at 3T using surface array coils. The DWI data sets were post-processed using monoexponential and kurtosis models, while T2w was standardized to a common scale. Local statistics and 8 different radiomics/texture descriptors were utilized at different configurations to extract a total of 7105 unique per-tumor features. Regularized logistic regression with implicit feature selection and leave pair out cross validation was used to discriminate tumors with 3+3 vs >3+3 GS. In total, 100 PCa lesions were analysed, of those 20 and 80 had GS of 3+3 and >3+3, respectively. The best model performance was obtained by selecting the top 1% features of T2w, ADCm and K with ROC AUC of 0.88 (95% CI of 0.82–0.95). Features from T2 mapping provided little added value. The most useful texture features were based on the gray-level co-occurrence matrix, Gabor transform, and Zernike moments. Texture feature analysis of DWI, post-processed using monoexponential and kurtosis models, and T2w demonstrated good classification performance for GS of PCa. In multisequence setting, the optimal radiomics based texture extraction methods and parameters differed between different image types.
- 8 July 2019
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (7) , e0217702
Open AccessRadiomics and machine learning of multisequence multiparametric prostate MRI: Towards improved non-invasive prostate cancer characterization
To develop and validate a classifier system for prediction of prostate cancer (PCa) Gleason score (GS) using radiomics and texture features of T2-weighted imaging (T2w), diffusion weighted imaging (DWI) acquired using high b values, and T2-mapping (T2). T2w, DWI (12 b values, 0–2000 s/mm2), and T2 data sets of 62 patients with histologically confirmed PCa were acquired at 3T using surface array coils. The DWI data sets were post-processed using monoexponential and kurtosis models, while T2w was standardized to a common scale. Local statistics and 8 different radiomics/texture descriptors were utilized at different configurations to extract a total of 7105 unique per-tumor features. Regularized logistic regression with implicit feature selection and leave pair out cross validation was used to discriminate tumors with 3+3 vs >3+3 GS. In total, 100 PCa lesions were analysed, of those 20 and 80 had GS of 3+3 and >3+3, respectively. The best model performance was obtained by selecting the top 1% features of T2w, ADCm and K with ROC AUC of 0.88 (95% CI of 0.82–0.95). Features from T2 mapping provided little added value. The most useful texture features were based on the gray-level co-occurrence matrix, Gabor transform, and Zernike moments. Texture feature analysis of DWI, post-processed using monoexponential and kurtosis models, and T2w demonstrated good classification performance for GS of PCa. In multisequence setting, the optimal radiomics based texture extraction methods and parameters differed between different image types.
- Open Access
- 1 July 2019
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 11, 1-8
Assessment of dosimetric and positioning accuracy of a magnetic resonance imaging-only solution for external beam radiotherapy of pelvic anatomy
- 1 July 2019
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 11, 1-8
Open AccessAssessment of dosimetric and positioning accuracy of a magnetic resonance imaging-only solution for external beam radiotherapy of pelvic anatomy
- 16 November 2017
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 45 (3) , 355-364
Prospective evaluation of 18F-FACBC PET/CT and PET/MRI versus multiparametric MRI in intermediate- to high-risk prostate cancer patients (FLUCIPRO trial)
The purpose of this study was to evaluate 18F-FACBC PET/CT, PET/MRI, and multiparametric MRI (mpMRI) in detection of primary prostate cancer (PCa).
- 16 November 2017
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 45 (3) , 355-364
Prospective evaluation of 18F-FACBC PET/CT and PET/MRI versus multiparametric MRI in intermediate- to high-risk prostate cancer patients (FLUCIPRO trial)
The purpose of this study was to evaluate 18F-FACBC PET/CT, PET/MRI, and multiparametric MRI (mpMRI) in detection of primary prostate cancer (PCa).
- 1 May 2017
- Published by Elsevier in Metabolism
- Vol. 70, 23-30
MR signal-fat-fraction analysis and T2* weighted imaging measure BAT reliably on humans without cold exposure
- 1 May 2017
- Published by Elsevier in Metabolism
- Vol. 70, 23-30
MR signal-fat-fraction analysis and T2* weighted imaging measure BAT reliably on humans without cold exposure
- 28 February 2016
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 77 (3) , 1249-1264
Fitting methods for intravoxel incoherent motion imaging of prostate cancer on region of interest level: Repeatability and gleason score prediction
Purpose: To evaluate different fitting methods for intravoxel incoherent motion (IVIM) imaging of prostate cancer in the terms of repeatability and Gleason score prediction.Methods: Eighty‐one patients with histologically confirmed prostate cancer underwent two repeated 3 Tesla diffusion‐weighted imaging (DWI) examinations performed using 14 b‐values in the range of 0–500 s/mm2 and diffusion time of 19.004 ms. Mean signal intensities of regions‐of‐interest were fitted using five different fitting methods for IVIM as well as monoexponential, kurtosis, and stretched exponential models. The fitting methods and models were evaluated in the terms of fitting quality [Akaike information criteria (AIC)], repeatability, and Gleason score prediction. Tumors were classified into three groups (3 + 3, 3 + 4, > 3 + 4). Machine learning algorithms were used to evaluate the performance of the combined use of the parameters. Simulation studies were performed to evaluate robustness of the fitting methods against noise.Results: Monoexponential model was preferred over IVIM based on AIC. The “pseudodiffusion” parameters demonstrated low repeatability and clinical value. Median “pseudodiffusion” fraction values were below 8.00%. Combined use of the parameters did not outperform the monoexponential model.Conclusion: Monoexponential model demonstrated the highest repeatability and clinical values in the regions‐of‐interest based analysis of prostate cancer DWI, b‐values in the range of 0–500 s/mm2. Magn Reson Med 77:1249–1264, 2017. © 2016 International Society for Magnetic Resonance in Medicine
- 28 February 2016
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 77 (3) , 1249-1264
Fitting methods for intravoxel incoherent motion imaging of prostate cancer on region of interest level: Repeatability and gleason score prediction
Purpose: To evaluate different fitting methods for intravoxel incoherent motion (IVIM) imaging of prostate cancer in the terms of repeatability and Gleason score prediction.Methods: Eighty‐one patients with histologically confirmed prostate cancer underwent two repeated 3 Tesla diffusion‐weighted imaging (DWI) examinations performed using 14 b‐values in the range of 0–500 s/mm2 and diffusion time of 19.004 ms. Mean signal intensities of regions‐of‐interest were fitted using five different fitting methods for IVIM as well as monoexponential, kurtosis, and stretched exponential models. The fitting methods and models were evaluated in the terms of fitting quality [Akaike information criteria (AIC)], repeatability, and Gleason score prediction. Tumors were classified into three groups (3 + 3, 3 + 4, > 3 + 4). Machine learning algorithms were used to evaluate the performance of the combined use of the parameters. Simulation studies were performed to evaluate robustness of the fitting methods against noise.Results: Monoexponential model was preferred over IVIM based on AIC. The “pseudodiffusion” parameters demonstrated low repeatability and clinical value. Median “pseudodiffusion” fraction values were below 8.00%. Combined use of the parameters did not outperform the monoexponential model.Conclusion: Monoexponential model demonstrated the highest repeatability and clinical values in the regions‐of‐interest based analysis of prostate cancer DWI, b‐values in the range of 0–500 s/mm2. Magn Reson Med 77:1249–1264, 2017. © 2016 International Society for Magnetic Resonance in Medicine
- 1 December 2015
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 33 (10) , 1212-1218
Diffusion-weighted imaging of prostate cancer: effect of b-value distribution on repeatability and cancer characterization
- 1 December 2015
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 33 (10) , 1212-1218
Diffusion-weighted imaging of prostate cancer: effect of b-value distribution on repeatability and cancer characterization
- Open Access
- 22 June 2015
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 75 (5) , 2130-2140
Relaxation along fictitious field, diffusion-weighted imaging, and T2mapping of prostate cancer: Prediction of cancer aggressiveness
Purpose To evaluate the performance of relaxation along a fictitious field (RAFF) relaxation time (TRAFF), diffusion-weighted imaging (DWI)-derived parameters, and T2 relaxation time values for prostate cancer (PCa) detection and characterization. Methods Fifty patients underwent 3T MR examination using surface array coils before prostatectomy. DWI was performed using 14 and 12 b values in the ranges of 0–500 s/mm2 and 0–2000 s/mm2, respectively. Repeated MR examination was performed in 16 patients. TRAFF, DWI-derived parameters (monoexponential, kurtosis, biexponential models), and T2 values were measured and averaged over regions of interest placed in PCa and normal tissue. Repeatability of TRAFF and DWI-derived parameters were assessed by coefficient of repeatability and intraclass correlation coefficient ICC(3,1). Areas under the receiver operating characteristic curve (AUCs) for PCa detection and Gleason score classification were estimated. The parameters were correlated with Gleason score groups using Spearman correlation coefficient (ρ). Results ICC(3,1) values for TRAFF were in the range of 0.82–0.92. TRAFF values had higher AUC values for Gleason score classification compared with DWI-derived parameters and T2. The RAFF method demonstrated the highest ρ value (−0.65). Conclusion In a quantitative region of interest–based analysis, RAFF outperformed DWI (“low” and “high” b values) and T2 mapping in the characterization of PCa. Magn Reson Med 75:2130–2140, 2016.
- 22 June 2015
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 75 (5) , 2130-2140
Open AccessRelaxation along fictitious field, diffusion-weighted imaging, and T2mapping of prostate cancer: Prediction of cancer aggressiveness
Purpose To evaluate the performance of relaxation along a fictitious field (RAFF) relaxation time (TRAFF), diffusion-weighted imaging (DWI)-derived parameters, and T2 relaxation time values for prostate cancer (PCa) detection and characterization. Methods Fifty patients underwent 3T MR examination using surface array coils before prostatectomy. DWI was performed using 14 and 12 b values in the ranges of 0–500 s/mm2 and 0–2000 s/mm2, respectively. Repeated MR examination was performed in 16 patients. TRAFF, DWI-derived parameters (monoexponential, kurtosis, biexponential models), and T2 values were measured and averaged over regions of interest placed in PCa and normal tissue. Repeatability of TRAFF and DWI-derived parameters were assessed by coefficient of repeatability and intraclass correlation coefficient ICC(3,1). Areas under the receiver operating characteristic curve (AUCs) for PCa detection and Gleason score classification were estimated. The parameters were correlated with Gleason score groups using Spearman correlation coefficient (ρ). Results ICC(3,1) values for TRAFF were in the range of 0.82–0.92. TRAFF values had higher AUC values for Gleason score classification compared with DWI-derived parameters and T2. The RAFF method demonstrated the highest ρ value (−0.65). Conclusion In a quantitative region of interest–based analysis, RAFF outperformed DWI (“low” and “high” b values) and T2 mapping in the characterization of PCa. Magn Reson Med 75:2130–2140, 2016.
- 2 June 2015
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 124 (2) , 237-245
Serum levels of GFAP and EGFR in primary and recurrent high-grade gliomas: correlation to tumor volume, molecular markers, and progression-free survival
Our aim was to study the association of two potential serum biomarkers glial fibrillary acidic protein (GFAP) and epidermal growth factor receptor (EGFR) with prognostic markers such as IDH1 mutation, tumor burden, and survival in patients with high-grade gliomas (HGG). Additionally, our objective was to evaluate the potential of serum EGFR as a surrogate marker for EGFR status in the tumor. Pre-operative serum samples were prospectively collected from patients with primary (n = 17) or recurrent (n = 10) HGG. Serum GFAP and EGFR levels were determined by ELISA and studied for correlation with molecular markers including EGFR amplification, tumor volume in contrast-enhanced T1-weighted MRI, and progression-free survival (PFS). Pre-operative serum GFAP level of ≥0.014 ng/ml was 86 % sensitive and 85 % specific for the diagnosis of glioblastoma. High GFAP was related to the lack of IDH1 mutation (P = 0.016), high Ki67 proliferation index (P < 0.001), and poor PFS (HR 5.9, CI 1.2–29.9, P = 0.032). Serum GFAP correlated with enhancing tumor volume in primary (r = 0.64 P = 0.005), but also in recurrent HGGs (r = 0.76 P = 0.011). In contrast, serum EGFR levels did not differ between HGG patients and 13 healthy controls, and were not related to EGFR status in the tumor. We conclude that high serum GFAP associates with IDH1 mutation-negative HGG, and poor PFS. Correlation with tumor burden in recurrent HGG implicates the potential of serum GFAP for detection of tumor recurrence. Our results suggest that circulating EGFR is not derived from glioma cells and cannot be used as a marker for EGFR status in the tumor.
- 2 June 2015
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 124 (2) , 237-245
Serum levels of GFAP and EGFR in primary and recurrent high-grade gliomas: correlation to tumor volume, molecular markers, and progression-free survival
Our aim was to study the association of two potential serum biomarkers glial fibrillary acidic protein (GFAP) and epidermal growth factor receptor (EGFR) with prognostic markers such as IDH1 mutation, tumor burden, and survival in patients with high-grade gliomas (HGG). Additionally, our objective was to evaluate the potential of serum EGFR as a surrogate marker for EGFR status in the tumor. Pre-operative serum samples were prospectively collected from patients with primary (n = 17) or recurrent (n = 10) HGG. Serum GFAP and EGFR levels were determined by ELISA and studied for correlation with molecular markers including EGFR amplification, tumor volume in contrast-enhanced T1-weighted MRI, and progression-free survival (PFS). Pre-operative serum GFAP level of ≥0.014 ng/ml was 86 % sensitive and 85 % specific for the diagnosis of glioblastoma. High GFAP was related to the lack of IDH1 mutation (P = 0.016), high Ki67 proliferation index (P < 0.001), and poor PFS (HR 5.9, CI 1.2–29.9, P = 0.032). Serum GFAP correlated with enhancing tumor volume in primary (r = 0.64 P = 0.005), but also in recurrent HGGs (r = 0.76 P = 0.011). In contrast, serum EGFR levels did not differ between HGG patients and 13 healthy controls, and were not related to EGFR status in the tumor. We conclude that high serum GFAP associates with IDH1 mutation-negative HGG, and poor PFS. Correlation with tumor burden in recurrent HGG implicates the potential of serum GFAP for detection of tumor recurrence. Our results suggest that circulating EGFR is not derived from glioma cells and cannot be used as a marker for EGFR status in the tumor.